Artelo biosciences to present at the h.c. wainwright 24th annual global investment conference

Solana beach, calif., sept. 07, 2022 (globe newswire) -- artelo biosciences, inc.  (nasdaq: artl) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that gregory d. gorgas, chief executive officer of artelo, will be presenting at the h.c. wainwright 24th annual global investment conference which is being held september 12 - 14, 2022. the event will include virtual participation as well as in-person participation at the lotte new york palace hotel in new york city.
ARTL Ratings Summary
ARTL Quant Ranking